Genital granulomatosis in male and female patients with Crohn's disease: Clinical presentation and treatment outcomes
| dc.contributor.author | Dederichs, F | |
| dc.contributor.author | Lesalnieks, Igor | |
| dc.contributor.author | Sladek, M | |
| dc.contributor.author | Tzivinikos, C | |
| dc.contributor.author | Hansen, R | |
| dc.contributor.author | Muñoz, Carmen | |
| dc.contributor.author | Pavli, Paul | |
| dc.contributor.author | Cavicchi, Mayran | |
| dc.contributor.author | Abitbol, Vered | |
| dc.contributor.author | Rahier, Jean-Francois | |
| dc.contributor.author | Vavricka, Stephan | |
| dc.date.accessioned | 2024-02-29T04:43:02Z | |
| dc.date.issued | 2018 | |
| dc.date.updated | 2022-10-09T07:18:49Z | |
| dc.description.abstract | Background: Genital granulomatosis [GG] is a metastatic form of Crohn’s disease [CD], characterised by granulomatous inflammation of the genital skin without contact with the gastrointestinal tract. Little is known about GG, as most publications are case reports or small series, and only sporadic in male cases. Methods and Aims: Cases of GG were retrospectively collected through the Collaborative Network For Exceptionally Rare case reports project of the European Crohn´s and Colitis Organisation. Results: A total of 43 patients [9 males, 34 females] were diagnosed as having GG, mostly as oedema and/or ulcers. Histological confirmation of granulomas was obtained in 70% of the cases. CD location was colonic or ileocolonic in 97% and perianal disease was documented in 57%. There was no significant difference between males and females in CD phenotype or genital lesions. GG was the first manifestation of inflammatory bowel disease [IBD] in one-third of the patients; these patients were younger at the time of GG occurrence and they all were non-smokers. GG occurred in the absence of gastrointestinal disease activity in 30% of the cases. Ten out of 11 patients [91%] responded to systemic corticosteroid treatment, 5/9 patients responded to immunomodulators, and 9/11 patients responded to anti-tumour necrosis factor alpha [TNF-α] agents. Conclusions: GG is a rare extraintestinal manifestation of CD. It mainly occurs among women, in the setting of colonic involvement of CD, and perianal disease is often associated. Most cases are successfully managed with systemic corticosteroids or anti-TNF agents. | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 1873-9946 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/315276 | |
| dc.language.iso | en_AU | en_AU |
| dc.publisher | Oxford University Press | en_AU |
| dc.rights | Copyright © 2017 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press | en_AU |
| dc.source | Journal of Crohn's and Colitis | en_AU |
| dc.subject | Crohn’s disease | en_AU |
| dc.subject | genital granulomatosis | en_AU |
| dc.subject | vulvar | en_AU |
| dc.subject | penile | en_AU |
| dc.subject | scrotal | en_AU |
| dc.title | Genital granulomatosis in male and female patients with Crohn's disease: Clinical presentation and treatment outcomes | en_AU |
| dc.type | Journal article | en_AU |
| local.bibliographicCitation.issue | 2 | en_AU |
| local.bibliographicCitation.lastpage | 203 | en_AU |
| local.bibliographicCitation.startpage | 197 | en_AU |
| local.contributor.affiliation | Dederichs, F, Kath. Krankenhaus Hagen | en_AU |
| local.contributor.affiliation | Lesalnieks, Igor, Klinikum Bogenhausen | en_AU |
| local.contributor.affiliation | Sladek, M, Jagiellonian University Medical College | en_AU |
| local.contributor.affiliation | Tzivinikos, C, Royal London Hospital | en_AU |
| local.contributor.affiliation | Hansen, R, Royal Hospital for Children | en_AU |
| local.contributor.affiliation | Muñoz, Carmen, Villafranca del Hospital Universitario de Basurto | en_AU |
| local.contributor.affiliation | Pavli, Paul, College of Health and Medicine, ANU | en_AU |
| local.contributor.affiliation | Cavicchi, Mayran, Cabinet Medical Créteil | en_AU |
| local.contributor.affiliation | Abitbol, Vered, Cochin Hospital | en_AU |
| local.contributor.affiliation | Rahier, Jean-Francois, CHU Dinant-Godinne | en_AU |
| local.contributor.affiliation | Vavricka, Stephan, Triemli Hospital | en_AU |
| local.contributor.authoruid | Pavli, Paul, u3683784 | en_AU |
| local.description.embargo | 2099-12-31 | |
| local.description.notes | Imported from ARIES | en_AU |
| local.identifier.absfor | 420202 - Disease surveillance | en_AU |
| local.identifier.ariespublication | u5369653xPUB63 | en_AU |
| local.identifier.citationvolume | 12 | en_AU |
| local.identifier.doi | 10.1093/ecco-jcc/jjx131 | en_AU |
| local.identifier.scopusID | 2-s2.0-85041286101 | |
| local.identifier.thomsonID | WOS:000423703000008 | |
| local.publisher.url | https://academic.oup.com/ | en_AU |
| local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal of Clinical Nursing - 2016 - Forbat - How and why are subcutaneous fluids administered in an advanced illness.pdf
- Size:
- 152.25 KB
- Format:
- Adobe Portable Document Format
- Description: